Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Oct 31, 2005
Commitments Test Entity - Third Quarter Report
Oct 14, 2005
Presentation Market Update - Oct 2005
Oct 04, 2005
Neuren Wins NZ Biotechnology Co of the Year Award
Oct 03, 2005
Response to ASX Share Price Query
Sep 06, 2005
Parkinsons & Hypertension patents issued
Aug 31, 2005
Half Yearly Report & Half Year Accounts
Aug 30, 2005
Neuren initiates Phase 2 trial
Aug 24, 2005
US Army Presents Neuren Research Results
Aug 08, 2005
Appendix 3B
Jul 29, 2005
Commitments Test Entity - Second Quarter Report
Previous
1
2
3
4
5
6
Next